TERLIVAZ TERLIPRESSIN FOR INJECTION

USPTO USPTO 2020 REGISTERED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark TERLIVAZ TERLIPRESSIN FOR INJECTION was filed as Word and figurative mark on 05/04/2020 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/13/2023. The current status of the mark is "REGISTERED".

Logodesign (Wiener Klassifikation)

#USPTO: 26.17.05 - Lines, horizontal, Horizontal line(s), band(s) or bar(s), Bars, horizontal, Bands, horizontal #USPTO: 26.17.09 - Lines, curved, Curved line(s), band(s) or bar(s), Bands, curved, Bars, curved #USPTO: 26.17.13 - Overlined words or letters, Underlined words or letters, Letters or words underlined and/or overlined by one or more strokes or lines

Trademark Details Last update: June 15, 2023

Trademark form Word and figurative mark
File reference 7081079
Register number 88900093
Application date May 4, 2020
Entry date June 13, 2023
Expiration date June 13, 2033

Trademark owner

College Business & Technology ParkCruiserath Road, Blanchardstown
D15TX2V Dublin 15
IE

Trademark representatives

195 North Arlington Heights Road 60089 Buffalo Grove US

goods and services

5 Pharmaceuticals

ID: 13